Patient leaflet - MURINE IRRITATION & REDNESS RELIEF
Irritation & Redness Relief
xxxxxx
Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Always use this medicine exactly as described in this leaflet or as your pharmacist has told you.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist if you need more information or advice.
- If you get any side effects, talk to your pharmacist or doctor. This includes any possible side effects not listed in this leaflet. See section 4.
- You must talk to a doctor if you do not feel better or if you feel worse after 24 hours.
What is in this leaflet:
-
1. What MURINE Irritation & Redness Relief is and what it is used for
-
2. What you need to know before you use MURINE Irritation & Redness Relief
-
3. How to use MURINE Irritation & Redness Relief
-
4. Possible side effects
-
5. How to store MURINE Irritation & Redness Relief
-
6. Contents of the pack and other information
Driving and using machines
If you experience blurring of vision, do not drive or operate machinery until your sight has cleared.
This medicine contains 0.034 mg benzalkonium chloride in each drop which is equivalent to 0.1 mg/ml. Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.
4. possible side effects
Like all medicines, MURINE Irritation & Redness Relief can cause side effects, although not everybody gets them.
- After putting in the eye drops, you may notice a slight widening of your pupil (the black circle in the centre of your eye). This is an expected and temporary effect.
- If you experience any eye pain or persistent vision changes, discontinue use and tell your pharmacist or doctor.
Reporting of side effects : If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed below. By reporting side effects you can help provide more information on the safety of this medicine.
Ireland : HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2. Tel: +353 1 6764971, Fax: +353 1 6762517, Website: , e-mail:
Malta : ADR Reporting, The Medicines Authority, GZR-1368 Gzira, Website: , e-mail:
United Kingdom : Yellow Card Scheme:
Website: or search for MHRA Yellow Card in the Google Play or Apple App Store.
6. contents of the pack and other information
- The active ingredient is naphazoline hydrochloride 0.012%w/v.
- The other ingredients are benzalkonium chloride, boric acid (E284), borax (E285), disodium edetate, and purified water.